Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.

Opinion

Case: 24-2002 Document: 59 Page: 1 Filed: 04/16/2025

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

REGENERON PHARMACEUTICALS, INC., Plaintiff-Appellee

v.

MYLAN PHARMACEUTICALS INC., BIOCON BIOLOGICS INC., Defendants-Appellants

AMGEN USA, INC., CELLTRION, INC., SAMSUNG BIOEPIS CO., LTD., FORMYCON AG, AMGEN INC., Defendants ______________________

2024-2002 ______________________

Appeal from the United States District Court for the Northern District of West Virginia in Nos. 1:22-cv-00061- TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:23-cv-00094-TSK- JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM, 1:24-cv-00039-TSK-JPM, 1:24-cv-00053-TSK, 1:24-md- 03103-TSK-JPM, Chief Judge Thomas S. Kleeh. ______________________

ORDER The parties, having so agreed, IT IS ORDERED THAT: Case: 24-2002 Document: 59 Page: 2 Filed: 04/16/2025

The above-captioned appeal is dismissed under Fed. R. App. P. 42(b) with each side to bear their own costs.

FOR THE COURT

April 16, 2025 Date

ISSUED AS A MANDATE: April 16, 2025